Tyck till om SwePub Sök
här!
Sökning: L773:1021 335X OR L773:1791 2431 >
High expression of ...
High expression of microRNA-200c predicts poor clinical outcome in diffuse large B-cell lymphoma
-
- Berglund, Mattias (författare)
- Uppsala universitet,Enheten för onkologi
-
- Hedström, Gustaf (författare)
- Uppsala universitet,Enheten för onkologi
-
- Amini, Rose-Marie (författare)
- Uppsala universitet,Molekylär och morfologisk patologi
-
visa fler...
-
- Enblad, Gunilla (författare)
- Uppsala universitet,Enheten för onkologi
-
- Thunberg, Ulf (författare)
- Uppsala universitet,Enheten för onkologi
-
visa färre...
-
(creator_code:org_t)
- 2012-12-10
- 2013
- Engelska.
-
Ingår i: Oncology Reports. - : Spandidos Publications. - 1021-335X .- 1791-2431. ; 29:2, s. 720-724
- Relaterad länk:
-
https://www.spandido...
-
visa fler...
-
https://urn.kb.se/re...
-
https://doi.org/10.3...
-
visa färre...
Abstract
Ämnesord
Stäng
- Diffuse large B-cell lymphoma (DLBCL) is a heterogeneous group of B-cell lymphomas. A new and important tool for understanding the biology and clinical course of DLBCL is microRNA expression. This study presents microRNA-200c expression data from 61 DLBCL patients treated with CHOP or R-CHOP. Patients with high microRNA-200c expression had a median survival of 20.3 months and a significantly shorter overall survival (P=0.019) compared to patients with low microRNA-200c expression, who had a median survival of 35.8 months. We also found that patients treated with R-CHOP only and displaying high microRNA-200c expression had a significantly shorter overall survival compared to patients with low microRNA-200c expression, where all patients were still alive at the time of the last follow-up (P=0.0036). Lastly, we found that patients with high microRNA-200c expression had a significantly shorter time from initial diagnosis to the first relapse compared to patients with low microRNA-200c expression (P=0.0001). To our knowledge, this is the first study showing that the expression of microRNA-200c affects the clinical outcome of DLBCL patients, and that microRNA-200c is involved in the biology of DLBCL development, although larger studies are necessary to confirm this. Further investigations may also help to elucidate the biological role of microRNA-200c in DLBCL.
Nyckelord
- Diffuse large B-cell lymphoma
- microRNA-200c
- Prognosis
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas